Search Results - "Boytim, Michelle L"

Combination of Sulindac and Eflornithine Delays the Need for Lower Gastrointestinal Surgery in Patients With Familial Adenomatous Polyposis: Post Hoc Analysis of a Randomized Clinical Trial by Balaguer, Francesc, Stoffel, Elena M., Burke, Carol Ann, Dekker, Evelien, Samadder, N. Jewel, Van Cutsem, Eric, Lynch, Patrick M., Wise, Paul E., Hüneburg, Robert, Lim, Ramona M., Boytim, Michelle L., Du, Wei, Bruckheimer, Elizabeth M., Cohen, Alfred, Church, James

“…Colectomy and proctocolectomy are the initial standard of care for patients with familial adenomatous polyposis. Pharmacotherapy to prevent the progression of…”
Get full text

phase I study of imexon plus gemcitabine as first-line therapy for advanced pancreatic cancer by Cohen, Steven J, Zalupski, Mark M, Modiano, Manuel R, Conkling, Paul, Patt, Yehuda Z, Davis, Peg, Dorr, Robert T, Boytim, Michelle L, Hersh, Evan M

“…Purpose Imexon is an aziridine-derived iminopyrrolidone which has synergy with gemcitabine in pancreatic cancer cell lines. Gemcitabine is a standard therapy…”
Get full text

Proliferating Cell Nuclear Antigen as the Cell Cycle Sensor for an HLA-Derived Peptide Blocking T Cell Proliferation by Ling, Xuefeng, Kamangar, Salar, Boytim, Michelle L, Kelman, Zvi, Huie, Philip, Lyu, Shu-Chen, Sibley, Richard K, Hurwitz, Jerard, Clayberger, Carol, Krensky, Alan M

“…Synthetic peptides corresponding to structural regions of HLA molecules are novel immunosuppressive agents. A peptide corresponding to residues 65-79 of the…”
Get full text

Inhibition of Cell Cycle Progression by a Synthetic Peptide Corresponding to Residues 65-79 of an HLA Class II Sequence: Functional Similarities but Mechanistic Differences with the Immunosuppressive Drug Rapamycin by Boytim, Michelle L, Lyu, Shu-Chen, Jung, Ron, Krensky, Alan M, Clayberger, Carol

“…A synthetic peptide corresponding to a region of the alpha1 alpha-helix of DQA03011 (DQ 65-79) inhibits the proliferation of human PBL and T cells in an…”
Get full text

Radiofrequency Tonsil Reduction by Nelson, Lionel M, Boytim, Michelle L

Get full text

Original Article A phase I study of imexon plus gemcitabine as first-line therapy for advanced pancreatic cancer by Cohen, Steven J., Zalupski, Mark M., Modiano, Manuel R., Conkling, Paul, Patt, Yehuda Z., Davis, Peg, Dorr, Robert T., Boytim, Michelle L., Hersh, Evan M.

Get full text

A human class II MHC-derived peptide antagonizes phosphatidylinositol 3-kinase to block IL-2 signaling by Boytim, M L, Lilly, P, Drouvalakis, K, Lyu, S C, Jung, R, Krensky, A M, Clayberger, C

“…MHC molecules bind antigenic peptides and present them to T cells. There is a growing body of evidence that MHC molecules also serve other functions. We and…”
Get full text